Since the 1950s, first-line treatment has been glucocorticoids that have indirect and direct effects ... the main causative mechanism is a decrease in platelet count due to antiplatelet antibodies. 2 ...

H. pylori test and treat in case of unexplained iron deficiency anemia n.m. n.m. H. pylori test and treat in case of idiopathic thrombocytopenic purpura n.m. n.m. MALToma: Mucosa-associated ...

Argenx had cash, cash equivalents, and other short-term investments totaling $3.4 billion as of the end of 2024, making it well-positioned to continue funding its pipeline and commercialization ...

Her hospital course was complicated by transaminitis. Her platelet count improved to normal on hospital day 5 after receiving intravenous steroids and intravenous immunoglobulin to treat her suspected ...

Laboratory results before treatment were recorded for analysis ... Systemic lupus erythematosus and idiopathic thrombocytopenic purpura (ITP) were diagnosed based on skin symptoms, thrombocytopenia ...

Therefore, HDACi may become new immunotherapeutic options for prophylaxis and treatment of GVHD or other immune diseases ... valproic acid; Treg, regulatory T; ITP, idiopathic thrombocytopenic purpura ...

In this piece, we include reporting tips, how vaccine side effects are tracked in the U.S., and what research shows about the ...

In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, ...

Received FDA approval for the treatment of chronic immune thrombocytopenic purpura (ITP) in adults in July 2014. Received FDA orphan drug designation for the treatment of dermatomyositis in April ...

Rituximab, a monoclonal antibody directed against the CD20 molecule found on pre-B cells and mature B cells (but not on plasma cells), was introduced in the late 1990s for the treatment of non ...